DDX10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.365000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.824000E-01
Normal-vs-Stage2
4.155800E-01
Normal-vs-Stage3
8.427800E-01
Normal-vs-Stage4
4.282600E-01
Stage1-vs-Stage2
8.114600E-01
Stage1-vs-Stage3
2.543200E-01
Stage1-vs-Stage4
8.788400E-01
Stage2-vs-Stage3
2.301600E-01
Stage2-vs-Stage4
6.922800E-01
Stage3-vs-Stage4
3.079800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.328600E-01
Normal-vs-AfricanAmerican
2.329000E-01
Normal-vs-Asian
9.112800E-01
Caucasian-vs-AfricanAmerican
3.620000E-01
Caucasian-vs-Asian
2.350600E-01
AfricanAmerican-vs-Asian
1.920560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.520800E-01
Normal-vs-Female
4.312400E-01
Male-vs-Female
9.262800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.553400E-01
Normal-vs-Age(41-60Yrs)
1.989400E-01
Normal-vs-Age(61-80Yrs)
5.950200E-01
Normal-vs-Age(81-100Yrs)
3.406000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.740000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.366000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.927600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.589800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.834600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.743800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.278000E-01
Normal-vs-Daily Drinker
5.813600E-01
Normal-vs-Weekly Drinker
6.092000E-01
Normal-vs-Occasional Drinker
3.180200E-01
Normal-vs-Social Drinker
3.712200E-01
Non Drinker-vs-Daily Drinker
9.388800E-01
Non Drinker-vs-Weekly Drinker
7.805000E-01
Non Drinker-vs-Occasional Drinker
6.566400E-01
Non Drinker-vs-Social Drinker
6.859600E-01
Daily Drinker-vs-Weekly Drinker
8.489200E-01
Daily Drinker-vs-Occasional Drinker
6.311800E-01
Daily Drinker-vs-Social Drinker
6.627400E-01
Weekly Drinker-vs-Occasional Drinker
4.848800E-01
Weekly Drinker-vs-Social Drinker
5.271800E-01
Occasional Drinker-vs-Social Drinker
9.997200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.832000E-01
Normal-vs-Grade 2
8.433200E-01
Normal-vs-Grade 3
7.519400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.677000E-03
Grade 1-vs-Grade 3
5.224200E-04
Grade 1-vs-Grade 4
9.832000E-01
Grade 2-vs-Grade 3
7.166400E-02
Grade 2-vs-Grade 4
8.433200E-01
Grade 3-vs-Grade 4
7.519400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.536000E-01
Normal-vs-NonDiabetic
4.202400E-01
Diabetic-vs-NonDiabetic
6.326400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.180200E-02
Normal-vs-NoPancreatitis
4.733000E-01
Pancreatitis-vs-NoPancreatitis
5.080300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.027200E-01
Normal-vs-N1
4.095000E-01
N0-vs-N1
9.195200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.109400E-01
Normal-vs-TP53-NonMutant
6.126000E-01
TP53-Mutant-vs-TP53-NonMutant
6.46149999999901E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
